Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Cemiplimab for Skin Cancer
Recruiting1 awardPhase 1
Atlanta, Georgia
This trial is testing a new cancer drug, cemiplimab, to see if it is safe and effective for treating patients with skin cancer. The study will also look at the side effects of the drug and how well it works.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service